NYU'S Duster cautions against FDA approval of 'race-based' pharmaceutical

New York University Sociologist Troy Duster concludes that a pharmaceutical to combat heart disease among blacks is based on faulty research and urges the Food and Drug Administration to obtain more reliable data before approving the drug. Duster, president of the American Sociological Association, writes that research on isosorbide dinitrate and hydralazine (BiDil), produced by NitroMed, incorrectly links a biological idea of race to heart disease and that socioeconomic factors better explain susceptibility to heart disease. Duster's analysis appears in Science magazine.

"Race is such a dominant category in the cognitive field that it can leave its own indelible mark once given even the temporary imprimatur of scientific legitimacy by molecular genetics," Duster writes, expressing concern for the precedent the NitroMed study may set.

However, Duster encourages continued research to match genetics and medical treatment.

"An increased understanding of genetic diversity will help scientists doing gene-association studies by identifying new variants and reducing the likelihood of false-positive associations," he writes. "The hope is that it may aid scientists to identify medically relevant genes for diseases."

Initially, the FDA rejected its use to treat heart disease because of its ineffectiveness among the general population. However, the company began testing BiDil exclusively on blacks with FDA approvalafter theorizing that the drug's effect on nitric-oxide deficiency, which is more common in black heart-failure patients than in non-blacks, would be beneficial to a targeted racial population. NitroMed reported effectiveness of the BiDil in its clinical trial of 400 black women and 600 black men.

NitroMed, which intends to market the drug to African Americans after FDA approval, has noted that African Americans between the ages of 45 and 64 are two-and-a-half times more likely to die from hear

Contact: James Devitt
New York University

Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. New study in Nature demonstrates protection against cell death during heart attack
3. Vaccine against childhood pneumonia shows promise
4. Mayo Clinic discovers new pathway against pancreatic cancer
5. Orthodontists must brace against back pain
6. Female sex hormones play a vital role in defense against sexually transmitted diseases
7. New European cancer figures for 2004 major efforts needed against the big four killers
8. New highly active agents against sandfly fever
9. New mosquito control strategy proves successful against dengue fever
10. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
11. Gene vaccine protects mice against development of Her2/neu breast cancer

Post Your Comments:

(Date:8/31/2020)... , ... August 31, 2020 , ... ... support services to dental groups in the United States, today announced the grand ... of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis ... are in a state of panic, experiencing deep anxiety, immense stress, and right now are ... is timely when most people on the planet are experiencing a great degree of emotional ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has ... with autism and other developmental disabilities, as well as supporting staff in caring ... with autism, school consultation, and staff development. She joined the company in 2015 ...
(Date:8/29/2020)... ... ... When professor and author Randy Pausch was diagnosed with pancreatic cancer, he accepted his ... however, he put together a final lecture in Carnegie Hall in which he offered ... and turned it into something that inspired millions of people worldwide. This inclination to ...
(Date:8/28/2020)... ... 28, 2020 , ... WHAT , Hespiro™ is a new ... conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It not ... and scrubs it free of carbon dioxide in a completely closed “rebreather” system, ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face ... https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests on Q&J’s personal face ... COVID-19 virus than many other masks. Q&J face masks have both mechanical filtering ...
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku Analytical Devices ... discussion among industry professionals about successes and challenges of making changes to their ... Review and will take place on October 15, 2020 at 10:00am PDT ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... laboratory technologies, will host the Agilent Science and Technology Virtual Symposium 2020 ... two-day symposium, Agilent will open a suite of Live webinars and Networking sessions, ...
Breaking Medicine Technology:
Cached News: